贝林司他(商标是Beleodaq,以前称为PXD101)是TopoTarget开发的用于治疗血液恶性肿瘤和实体肿瘤的组蛋白去乙酰化酶抑制剂。
BD98022905-24-097%
¥40.005g常备现货
BD627888659-04-198%
¥1014.00100mg常备现货
BD627889163487-10-397%
¥557.00250mg常备现货
BD8919717625-03-595%
¥63.0025g常备现货
BD3444563555-50-096%
¥225.001g常备现货
BD1554445927-18-498%
¥30.005g常备现货
BD3557299-61-697%
¥44.0025g常备现货
BD249626610801-82-695+%
¥2785.001g
BD6334951137621-29-497%
¥暂无
BD317430166338-06-395+%
¥暂无
BD249627610801-83-795+%
¥2363.00250mg
BD304964866323-86-695+%
¥997.00250mg
BD2473465330-48-395+%
¥7862.405g
BD629798866323-87-797%
¥5304.00100mg